Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma.

@article{Jia2018ForkheadboxSE,
  title={Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma.},
  author={Zhongwei Jia and F. Wan and Y. Zhu and G. Shi and Hailiang Zhang and B. Dai and D. Ye},
  journal={Oncology letters},
  year={2018},
  volume={15 6},
  pages={
          8669-8680
        }
}
Previous studies have demonstrated that several members of the Forkhead-box (FOX) family of genes are associated with tumor progression and metastasis. The objective of the current study was to screen candidate FOX family genes identified from analysis of molecular networks in clear cell renal cell carcinoma (ccRCC). The expression of FOX family genes as well as FOX family-associated genes was examined, and Kaplan-Meier survival analysis was performed in The Cancer Genome Atlas (TCGA) cohort (n… Expand
Forkhead box F2 as a novel prognostic biomarker and potential therapeutic target in human cancers prone to bone metastasis: a meta-analysis
  • Qing Chen, Lei Zhou, +4 authors Jian Dong
  • Medicine
  • The Journal of international medical research
  • 2021
TLDR
Findings indicate that high FOXF2 levels could be an indicator of a good prognosis in cancer patients with tumours that are prone to bone metastasis and might be a clinically important prognostic biomarker. Expand
Increased expression of FOXD1 is associated with cervical nodes metastasis and unfavorable prognosis in oral squamous cell carcinoma.
  • Z. Li, Tingyuan Yan, +4 authors Jianrong Yang
  • Medicine
  • Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • 2020
TLDR
Findings indicate that the aberrant up-regulation of FOXD1 is related to cervical nodes metastasis and unfavorable prognosis in OSCC and it also may play a key role during OSCC tumorigenesis and regard as a novel diagnostic as well as prognostic biomarker for OSCC. Expand
FOXK2 Transcription Factor and Its Emerging Roles in Cancer
TLDR
The emerging functions of FOXK2 as a regulator of a broad range of cancer features, such as cell proliferation and survival, DNA damage, metabolism, migration, invasion and metastasis are explored. Expand
A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma
TLDR
The nine-mRNA methylation signature (DMRTA2, DRGX, FAM167A, FGGY, FOXI2, KRTAP2-1, TCTEX1D 1, TTBK1, and UBE2QL1) may be a useful prognostic biomarker and tool for ccRCC patients. Expand
Novel molecular signatures and potential therapeutics in renal cell carcinomas: Insights from a comparative analysis of subtypes.
TLDR
A comparative analysis was performed on RNA-seq based transcriptome data from each RCC subtype, namely clear cell RCC, papillary RCC (KIRP) and kidney chromophobe (KICH), and mutual or subtype-specific reporter biomolecules were identified by the integration of expression profiles with genome-scale biomolecular networks. Expand
FOXK2 downregulation suppresses EMT in hepatocellular carcinoma
TLDR
It is revealed that FOXK2 downregulation suppressed the EMT in HCC partly through inhibition of the Akt signaling pathway. Expand
Sonic Hedgehog signaling pathway in gynecological and genitourinary cancer (Review)
TLDR
The present review aimed to provide an in-depth summary of the SHH signaling pathway, including the characterization of its major components, the mechanism of its upstream regulation and non-canonical activation, as well as its interactions with other cellular pathways. Expand
MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1
TLDR
It is found that overexpression of miR-338-5p suppresses glioma cell proliferation, migration, and invasion and accelerates its senescence and apoptosis by decreasing FOXD1 expression via inhibition of activation of MAPK-signaling pathway. Expand
LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis.
TLDR
Elevated NORAD works as a sponge for miR-211-5p in HCC, thus release the inhibition effect of the latter on its downstream target FOXD1 and VEGF-A, which finally promotes angiogenesis. Expand

References

SHOWING 1-10 OF 37 REFERENCES
ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients
TLDR
Genes of integrin family that showed certain correlations with overall survival (OS) were further validated in the Fudan University Shanghai Cancer Center (FUSCC) cohort and identified as independent prognostic factors of overall survival of ccRCC. Expand
Transcriptomic profiling of Forkhead box transcription factors in adult glioblastoma multiforme.
TLDR
The data provide the first comprehensive clinical evidence that FOXA2, FOXN2, FoxN3 and FOXG1 are promising biomarkers of GBM and warrant further investigation. Expand
Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.
TLDR
Analysis of human tumor specimens confirmed a significant relationship between loss of FoxA1 and increased cytokeratin 14 expression and application of a univariate analysis and a multivariate Cox proportional hazards regression model revealed that loss of FOXA1 expression is an independent predictor of decreased overall survival. Expand
Gene expression profiling: canonical molecular changes and clinicopathological features in sporadic colorectal cancers.
TLDR
It is shown that several differentially expressed genes were associated with canonical molecular changes in sporadic colorectal cancers, possibly constituting alternative or subordinate pathways of tumorigenesis. Expand
FOXA2 mRNA expression is associated with relapse in patients with Triple-Negative/Basal-like breast carcinoma
TLDR
The results suggest that FOXA2 promotes cell proliferation, maintains cancer stem cells, favors the development of Triple-Negative/Basal-like tumors, and is associated with increase relapses. Expand
FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer.
TLDR
It is reported that higher expression of FOXL1 is significantly associated with better clinical outcome in human pancreatic ductal adenocarcinoma (PDAC) and it plays an inhibitory role in pancreatic tumor progression. Expand
FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27.
TLDR
It is found that FOXD1 is up-regulated in breast cancer tissues and may be a potential therapy target for patients with breast cancer. Expand
The Transcription Factor FOXA2 Suppresses Gastric Tumorigenesis In Vitro and In Vivo
TLDR
It is suggested that FOXA2 induces the differentiation of gastric cancer and is highlighted as a novel therapeutic target and prognostic marker for human Gastric cancer. Expand
NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis.
TLDR
An NCOA1/AP-1/CSF1 regulatory axis that promotes breast cancer metastasis is defined, offering a novel therapeutic target for impeding this process. Expand
FOXA2 regulates a network of genes involved in critical functions of human intestinal epithelial cells.
TLDR
Data show that FOXA2 plays a pivotal role in regulating intestinal epithelial cell function and that the FOXA and GATA families of transcription factors may work cooperatively to regulate gene expression genome-wide in the intestinal epithelium. Expand
...
1
2
3
4
...